| Syneron wins $6m order from American Laser Centers
Aesthetic surgical devices maker Syneron Medical Ltd. (Nasdaq: ELOS) is expanding its collaboration with US clinics chain American Laser Centers. Exactly 11 months after Syneron announced that it would supply the chain with its VelaSmooth and Aurora products, it has received has received an order from the company worth an initial $6 million. Syneron will supply American Laser Centers with devices from its eLine product line, considered one of the companys growth engines. Syneron currently has three products in this line: eLight is a treatment for acne, superficial benign vascular and pigmented lesions: eLaser removes hair and treats vascular veins; and eMax is a work station for the companys electro-optical synergy (ELOS) technology. Under the present contract, Syneron will deliver its eLaser and eLight products to 120 American Laser Centers clinics across the US.
Getting Buy: The costs of plastic surgery
Everyone, it seems, has something about themselves that they wish could be changed; a large nose, small breasts and baggy eyes are all common complaints. Plastic surgery has become more affordable and the technology has advanced dramatically over the last few decades. But can you afford it? One of the most popular procedures is breast augmentation (or, "boob-job" to the layperson). According to the American Society for Aesthetic Plastic Surgery, the national average cost for this operation is $3,360, or, $1,680 each. Keep in mind, that price DOES NOT include the operation room fee, which varies by hospital, anesthesia, supplies or the implants themselves. So you can plan on spending at least an extra $2,000 on top of the surgeon’s fee. Still think it’s worth the price? You must factor in the cost of prescriptions, time off of work (generally a week), new bras, which cost an ungodly $50 each, new shirts to fit your new sweater cows, and then there’s the time used to prepare an explanation.
Cutera Takes 2Q Loss on Legal Charge
Cutera Inc., which makes laser skin treatments used by dermatologists and plastic surgeons, on Monday said it swung to a second-quarter loss, weighed down by $22 million patent settlement with rival Palomar Medical Technologies. The company posted a loss of $9 million, or 73 cents per share, compared with a profit of $2.7 million, or 20 cents per share, a year ago. Cutera anticipated the loss in June and lowered its guidance to a loss of 89 cents per share from a 12-cent gain. Excluding the legal charge and stock option expenses, the company said it earned 20 cents per share. Analysts polled by Thomson Financial expected, on average, earnings of 9 cents per share. Revenue jumped 38.8 percent to $24.4 million from $17.6 million. Analysts expected revenue of $22.8 million.
|